Peer Exchange

Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding relapsed/refractory multiple myeloma (MM).

Key opinion leaders discuss the disease state, treatment landscape, and future considerations for treating patients with myelodysplastic syndrome (MDS).

Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.

Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.

A panel of medical experts discuss treating acute myeloid leukemia (AML), from diagnosis to the different therapies available that give patients the best chance at survival.

Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.

In this Pharmacy Times Peer Exchange, a panel of pharmacists discuss treatment options for patients with atopic dermatitis, from systemic agents to topical agents, including the new developments occurring with JAK inhibitors.

A panel of key opinion leaders in cardiology and pharmacy provides a lively discussion on currently available and emerging therapeutic approaches for the treatment of heart failure.

What pharmacists need to know about managing patients who are prescribed more recent acute and preventive treatment options approved for migraine.